Next episode - February 6 , 2025 // 1:00 PM CET
Episode 3 - Why look for pelvic varicose?
March 6, 2025 // 1:00 pm CET
Join us on March 6th, 2025, at 1:00 PM CET for the 3rd episode in this MOH series Pelvic varicose: A mystery to explore titled Why look for pelvic varicose?
Renowned experts Dr. Philippe Lemasle and Prof. Ismaïl Elalamy will delve into:
- The importance of detecting pelvic varicose veins
- Challenges for vascular doctors, gynecologists, and midwives
- The role of pelvic origin leak points (LP) in conjunction with varicose veins in the lower limbs
- Q&A session in French with English translation
Mark your calendar and don’t miss this insightful event!
Rejoignez-nous le 6 Mars 2025 à 13h00 pour le 3ème épisode de cette série du MOH sur la varicose pelvienne, intitulé Pourquoi rechercher une varicose pelvienne?
Les experts renommés Dr Philippe Lemasle et Pr Ismaïl Elalamy aborderont:
- L’anatomie des varices pelviennes.
- Défis pour les médecins vasculaires, les gynécologues et les sages-femmes.
- Le rôle des points de fuite (LP) d'origine pelvienne en lien avec les varices des membres inférieurs.
- Points suivis de 30 min de questions/réponses en direct.
Marquez votre calendrier et ne manquez pas cet événement instructif!
Speakers
Dr. Philippe Lemasle, FR
Vascular doctor in Le Chesnay, FR; Specialties: Vascular medicine, Angiologist/Phlebologist; Since May 1987 exclusive private practice of Vascular Medicine; Teacher of the university diploma of phlebology (Pierre and Marie Curie University - Paris VI); Teacher of the Algerian Society of Vascular Medicine; Full member of the French Society of Vascular Medicine and the French Society of Phlebology
2022 - Ordinary qualification as a specialist in vascular medicine
(Profile)
Prof. Ismaïl Elalamy (FR)
A Professor of Haematology and has been the Head of the Haematology Department at Tenon University Hospital, Médecine Sorbonne Université Paris, and current President of the French Society of Angiology. Prof Elalamy has been involved in the field of thrombosis and antithrombotic therapies since 1991, and his research interests include improving therapeutic strategies, identifying new biomarkers and the application of novel diagnostic techniques to the clinic.
(LinkedIn)